1. Home
  2. DRTS vs GIII Comparison

DRTS vs GIII Comparison

Compare DRTS & GIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

N/A

Current Price

$13.40

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Logo G-III Apparel Group LTD.

GIII

G-III Apparel Group LTD.

N/A

Current Price

$31.71

Market Cap

1.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
DRTS
GIII
Founded
2015
1956
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
DRTS
GIII
Price
$13.40
$31.71
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
$20.60
★ $34.75
AVG Volume (30 Days)
★ 502.7K
386.5K
Earning Date
11-27-2026
12-08-2026
Dividend Yield
N/A
★ 1.27%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 1.95
Revenue
N/A
★ $2,957,012,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1,793.58
$1.17
P/E Ratio
★ N/A
$16.18
Revenue Growth
★ N/A
N/A
52 Week Low
$3.43
$24.61
52 Week High
$15.79
$37.54

Technical Indicators

Market Signals
Indicator
DRTS
GIII
Relative Strength Index (RSI) 47.69 60.28
Support Level $12.33 $26.69
Resistance Level $13.95 $32.58
Average True Range (ATR) 0.64 0.91
MACD 0.06 0.06
Stochastic Oscillator 38.02 58.72

Price Performance

Historical Comparison
DRTS
GIII

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About GIII G-III Apparel Group LTD.

G-III Apparel Group Ltd is an apparel manufacturing company. The company makes a wide range of apparel, footwear, and accessories that sells under its own brands, licensed brands, and private-label brands. It has a substantial portfolio for licensed and proprietary brands, anchored by brands: DKNY, Donna Karan, Karl Lagerfeld, Karl Lagerfeld Paris, Vilebrequin, and others. The reportable segments of the company are Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, and sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenue from Wholesale operations.

Share on Social Networks: